JP2021524485A5 - - Google Patents
Info
- Publication number
- JP2021524485A5 JP2021524485A5 JP2021500530A JP2021500530A JP2021524485A5 JP 2021524485 A5 JP2021524485 A5 JP 2021524485A5 JP 2021500530 A JP2021500530 A JP 2021500530A JP 2021500530 A JP2021500530 A JP 2021500530A JP 2021524485 A5 JP2021524485 A5 JP 2021524485A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- polypeptide
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024109065A JP2024153666A (ja) | 2018-07-11 | 2024-07-05 | パラ結核症のための免疫原性組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1811382.9 | 2018-07-11 | ||
| GBGB1811382.9A GB201811382D0 (en) | 2018-07-11 | 2018-07-11 | Vaccine |
| PCT/GB2019/051933 WO2020012177A1 (en) | 2018-07-11 | 2019-07-10 | Immunogenic composition for paratuberculosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024109065A Division JP2024153666A (ja) | 2018-07-11 | 2024-07-05 | パラ結核症のための免疫原性組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021524485A JP2021524485A (ja) | 2021-09-13 |
| JP2021524485A5 true JP2021524485A5 (enExample) | 2022-07-12 |
Family
ID=63273113
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500530A Pending JP2021524485A (ja) | 2018-07-11 | 2019-07-10 | パラ結核症のための免疫原性組成物 |
| JP2024109065A Pending JP2024153666A (ja) | 2018-07-11 | 2024-07-05 | パラ結核症のための免疫原性組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024109065A Pending JP2024153666A (ja) | 2018-07-11 | 2024-07-05 | パラ結核症のための免疫原性組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US12186382B2 (enExample) |
| EP (1) | EP3820507A1 (enExample) |
| JP (2) | JP2021524485A (enExample) |
| KR (1) | KR20210033490A (enExample) |
| CN (1) | CN113329765A (enExample) |
| AU (1) | AU2019301899A1 (enExample) |
| BR (1) | BR112021000312A2 (enExample) |
| CA (1) | CA3105763A1 (enExample) |
| GB (1) | GB201811382D0 (enExample) |
| IL (1) | IL280070B2 (enExample) |
| MA (1) | MA53131A (enExample) |
| MX (1) | MX2020013924A (enExample) |
| SG (1) | SG11202100120TA (enExample) |
| WO (1) | WO2020012177A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201700487D0 (en) * | 2017-01-11 | 2017-02-22 | Hermon-Taylor John | Diagnostic |
| WO2026041756A1 (en) | 2024-08-21 | 2026-02-26 | Hav Vaccines Limited | Treatment of crohn's disease by mycobacterium avium subsp. paratuberculosis agent |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US5225324A (en) | 1987-04-24 | 1993-07-06 | Bioscience International, Inc. | Diagnostics for mycobacteria in public health, medical, and veterinary practice |
| GB8709803D0 (en) | 1987-04-24 | 1987-05-28 | Mcfadden J J | Treatment of crohn's disease &c |
| DK0737750T3 (da) | 1989-03-21 | 2003-09-01 | Vical Inc | Ekspression af exogene polynucleotidsekvenser i vertebrater |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US5279833A (en) | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
| US5283185A (en) | 1991-08-28 | 1994-02-01 | University Of Tennessee Research Corporation | Method for delivering nucleic acids into cells |
| JPH07505283A (ja) | 1992-03-20 | 1995-06-15 | ベイラー・カレッジ・オブ・メディシン | Ｄｎａトランスポーター系および使用方法 |
| AU682308C (en) | 1992-04-03 | 2006-08-17 | Regents Of The University Of California, The | Self-assembling polynucleotide delivery system |
| US5651981A (en) | 1994-03-29 | 1997-07-29 | Northwestern University | Cationic phospholipids for transfection |
| US5527928A (en) | 1994-09-30 | 1996-06-18 | Nantz; Michael H. | Cationic transport reagents |
| GB9526178D0 (en) | 1995-12-21 | 1996-02-21 | Taylor John Hermon | Novel polynuceotides and polypeptides in pathogenic mycobacteria and their use as diagnostics,vaccines and targets for chemotherapy |
| GB9806093D0 (en) | 1998-03-20 | 1998-05-20 | Taylor John Hermon | Diagnostics and vaccines for mycobacterial infections of animals and humans |
| US7074559B2 (en) * | 2002-03-06 | 2006-07-11 | Refents of the University of Minnesota | Mycobacterial diagnostics |
| ATE466876T1 (de) | 2005-08-09 | 2010-05-15 | Hav Vaccines Ltd | Immunogene konstrukte |
| US8609097B2 (en) | 2009-06-10 | 2013-12-17 | Hoffmann-La Roche Inc. | Use of an anti-Tau pS422 antibody for the treatment of brain diseases |
| CN102596236B (zh) | 2009-07-30 | 2015-06-24 | 辉瑞疫苗有限责任公司 | 抗原性Tau肽及其用途 |
| EP2710151A4 (en) | 2011-05-19 | 2014-12-10 | Univ Central Florida Res Found | MICROBEND DETECTION BY HYBRIDIZATION OF MAGNETIC RELAXATION NANOSENSORS |
| WO2014016737A1 (en) | 2012-07-24 | 2014-01-30 | Pfizer Inc. | Novel chicken monoclonal antibodies against human phosphorylated tau and uses thereof |
| JP2016513078A (ja) * | 2013-01-28 | 2016-05-12 | ダンマルクス テクニスケ ウニベルシテット | 一段階または多段階のトリ型結核菌亜種副結核症サブユニット・ワクチン |
| GB201700487D0 (en) * | 2017-01-11 | 2017-02-22 | Hermon-Taylor John | Diagnostic |
-
2018
- 2018-07-11 GB GBGB1811382.9A patent/GB201811382D0/en not_active Ceased
-
2019
- 2019-07-10 KR KR1020217004231A patent/KR20210033490A/ko not_active Ceased
- 2019-07-10 CA CA3105763A patent/CA3105763A1/en active Pending
- 2019-07-10 JP JP2021500530A patent/JP2021524485A/ja active Pending
- 2019-07-10 MA MA053131A patent/MA53131A/fr unknown
- 2019-07-10 IL IL280070A patent/IL280070B2/en unknown
- 2019-07-10 WO PCT/GB2019/051933 patent/WO2020012177A1/en not_active Ceased
- 2019-07-10 BR BR112021000312-6A patent/BR112021000312A2/pt unknown
- 2019-07-10 MX MX2020013924A patent/MX2020013924A/es unknown
- 2019-07-10 AU AU2019301899A patent/AU2019301899A1/en not_active Abandoned
- 2019-07-10 SG SG11202100120TA patent/SG11202100120TA/en unknown
- 2019-07-10 US US17/259,075 patent/US12186382B2/en active Active
- 2019-07-10 CN CN201980059761.5A patent/CN113329765A/zh active Pending
- 2019-07-10 EP EP19752222.0A patent/EP3820507A1/en active Pending
-
2024
- 2024-07-05 JP JP2024109065A patent/JP2024153666A/ja active Pending
- 2024-11-20 US US18/954,032 patent/US20250152691A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023506765A5 (enExample) | ||
| JP2023518596A5 (enExample) | ||
| JP2023505492A5 (enExample) | ||
| JP2018150386A (ja) | Ｏｓｐａキメラおよびそのワクチンでの使用法 | |
| JP2008538183A5 (enExample) | ||
| KR20120083899A (ko) | 마이코박테리아 백신들 | |
| JP2023528207A5 (enExample) | ||
| TW200842189A (en) | DNA vaccine for Koi herpes virus (KHV) disease | |
| JP2006502702A5 (enExample) | ||
| JP2018537089A5 (enExample) | ||
| Franchini et al. | Cloning and purification of the rainbow trout fifth component of complement (C5) | |
| JP2015524802A (ja) | キメラｏｓｐａ分子を含む組成物およびその使用方法 | |
| CN109010799B (zh) | RyR2蛋白或RyR2重组蛋白在制备抗心力衰竭药物中的用途 | |
| JP2004535161A5 (enExample) | ||
| US7531177B2 (en) | Surface protein of leptospira | |
| CN114401730A (zh) | 免疫调节组合物和方法 | |
| KR20170077252A (ko) | Hnp-1 또는 hnp-2 또는 hnp-3을 인코딩하는 플라스미드 dna, 박테리아 제조체, 진통제 (변이체) | |
| JP2009507474A5 (enExample) | ||
| JP2005536182A (ja) | 魚由来のカセリシジンファミリーのペプチド及び核酸、及びその使用 | |
| JP2009504149A5 (enExample) | ||
| US9562080B2 (en) | Lyme disease vaccine, genetic construct, recombinant protein, method for designing genetic construct, method for producing vaccine, method for producing recombinant proteins, use of recombinant proteins in the production of lyme disease vaccine | |
| JP2014502164A (ja) | 細胞表面で発現される抗菌ペプチド多重合複合体 | |
| JP2024534178A5 (enExample) | ||
| CN101880328A (zh) | 微小隐孢子虫Th多表位基因和融合蛋白及其应用 | |
| JP2008503569A5 (enExample) |